X

Trial Profile

JAPANESE - Skin Toxicity Evaluation Protocol With Panitumumab as 3rd line treatment for Colorectal Cancer(J-STEPP),(HGCSG1001)

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 04 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Panitumumab (Primary)
Indications Colorectal cancer
Focus Adverse reactions
Acronyms J-STEPP

Most Recent Events

06 Jun 2017 Results from STEPP and J-STEPP studies, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
18 Jan 2014 Results presented at the 2014 Gastrointestinal Cancers Symposium.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com